Mitul Patel, MD
Vascular Surgery · Ridgewood, NJNPI 1093045197
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (38.3%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Inari Medical, Inc. at 43.8% of the total. Reporting peaked in 2022 at $35,248 and has fallen 90.7% since, to $3,271 in 2025. Among vascular surgery clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 255 payments — averaging $214.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inari Medical, Inc.$24K
- Medtronic$17K
- Penumbra, Inc.$3K
- Cook Incorporated$3K
- W. L. Gore & Associates, Inc.$1K
- Silk Road Medical, Inc.$1K
- plus $6K from 24 others
Across 11 payments — averaging $2343.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Inari Medical, Inc.$23K
- Angiodynamics, Inc.$3K
What the payments were for
- Consulting fees$16,90031%
- Speaking & faculty fees$2,5005%
- Travel & lodging$20,98738%
- Food & beverage$14,34926%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inari Medical, Inc. | 54 | $24,000 |
| Medtronic(3 entities) | 78 | $16,743 |
| Penumbra, Inc. | 14 | $2,675 |
| Cook Incorporated | 1 | $2,500 |
| W. L. Gore & Associates, Inc. | 12 | $1,265 |
| Silk Road Medical, Inc. | 8 | $1,113 |
| Stryker | 7 | $934 |
| Cook Medical LLC | 13 | $894 |
| Cardiovascular Systems Inc. | 18 | $873 |
| Terumo Medical Corporation | 7 | $813 |
| Shockwave Medical, Inc | 5 | $581 |
| Johnson & Johnson | 11 | $557 |
| Endologix LLC | 3 | $277 |
| Philips North America LLC | 3 | $271 |
| Abbott | 4 | $195 |
| Globus Medical | 2 | $192 |
| Cvrx, Inc. | 1 | $134 |
| Bard Peripheral Vascular, Inc. | 1 | $126 |
| Boston Scientific | 1 | $123 |
| Mozarc Medical US LLC | 1 | $119 |
| EKOS Corporation | 1 | $118 |
| Argon Medical Devices, Inc. | 1 | $45 |
| Abiomed | 2 | $37 |
| Imperative Care, Inc | 1 | $28 |
| Baxter Healthcare | 1 | $27 |
| Tactile Systems Technology Inc | 1 | $22 |
| Angiodynamics, Inc. | 1 | $22 |
| Lemaitre Vascular, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $15 |
| Cashflow Solutions, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FLOWTRIEVER CATHETER, S$23,869
- CT THROMBECTOMY SYSTEM KIT$23,220
- IN.PACT Admiral$11,052
- Zenith Spiral-Z$2,895
- Indigo System$2,144
- Valiant Captivia$1,963
- ENROUTE Transcarotid Neuroprotection System$1,078
- ENROUTE Transcarotid Stent System$955
- ENHANCE Transcarotid Peripheral Access Kit$955
- ENROUTE 0.014 Guidewire$955
- CLOTTRIEVER BOLD CATHETER$617
- GORE TAG Conformable Thoracic Endoprosthesis$607
- ELLIPSYS VASCULAR ACCESS SYSTEM$467
- Navicross$463
- ENDURANT IIS$400
- XARELTO$383
- CONCERTOTM$338
- HawkOne$306
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$297
- METACROSS OTW$278
How this compares
$54,736 in reported general payments places this provider in the 90th percentile of 182 vascular surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 92 | $92,939 |
| XareltoRivaroxaban | 54 | $65,562 |
| ClopidogrelClopidogrel Bisulfate | 26 | $488 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 38 | $106 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $557 | $65,56254 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 182 vascular surgery providers in New Jersey.
Other vascular surgery in Ridgewood
- Steven EliasEnglewood$509K
- Michael WildermanHackensack$383K
- David O'ConnorHackensack$272K
- Joseph LombardiPomona$266K
- William BeckermanNew Brunswick$176K
- Neil PoulsenRockaway$148K
- Massimo NapolitanoWayne$147K
- Laurel HastingsCamden$98K
- Danielle PinedaPomona$97K
- Saum RahimiNew Brunswick$90K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.